The impact of different antimigraine compounds on platelet and erythrocyte aggregation

Cephalalgia

Volumn 26, Issue 8, 2006, Pages 920-924

  Evers, S ^a   Heuel, T ^a   Frese, A ^a   Akova Ozturk E ^a   Husstedt, I W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Ergotamine; Erythrocyte aggregation; Platelet aggregation; Sumatriptan; Zolmitriptan

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMIGRAINE AGENT; ERGOTAMINE TARTRATE; PLACEBO; SUMATRIPTAN; ZOLMITRIPTAN;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ERYTHROCYTE AGGREGATION; EX VIVO STUDY; FEMALE; HUMAN; MALE; MIGRAINE AURA; PHOTOMETRY; SEX DIFFERENCE; SIDE EFFECT; SINGLE BLIND PROCEDURE; THROMBOCYTE AGGREGATION;

ADULT; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ERGOTAMINE; ERYTHROCYTE AGGREGATION; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; PLATELET AGGREGATION; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 33746069403     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01146.x     Document Type: Article

References (23)

1. Meyler WJ. Side effects of ergotamine. Cephalalgia 1996; 16:5-10.
2. Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Lainez M, Henry P et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 2000; 123:9-18.
3. 1B/1D receptor agonists in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA editors. The headaches. Philadelphia: Lippincott Williams & Wilkins 2000:411-38.
4. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004; 62:563-8.
5. Barenbrock M, Spieker C, Witta J, Evers S, Hoeks APG, Rahn KH, Zidek W. Reduced distensibility of the common carotid artery in patients treated with ergotamine. Hypertension 1996; 28:115-9.
6. Tfelt-Hansen P. The effects of ergotamine on the arterial system in man. Acta Pharmacol Toxicol 1986; 59 (Suppl. 3):1-30.
7. Tozzi-Ciancarelli MG, Di Massimo C, Tozzi E, Mascioli A, De Matteis G, Carolei A. Influence of selective 5HT1-receptor agonist GR43175 on platelet responsiveness. Cephalalgia 1995; 15:472-36.
8. Barthel W, Markwardt F. Aggregation of blood platelets by biogenic amines and its inhibition by antiadrenergic and antiserotoninergic agents. Biochem Pharmacol 1974; 23:37-45.
9. Grotemeyer KH, Scharafinski HW, Husstedt IW. Two year follow-up of aspirin responder and aspirin nonresponder. Thromb Res 1993; 71:397-403.
10. Pütter M, Grotemeyer KH, Würthwein G, Araghi-Niknam M, Watson RR, Hosseini S, Rohdewald P. Inhibition of smoking-induced platelet aggregation by aspirin and pycnogenol. Thromb Res 1999; 95:155-61.
11. D'Andrea G, Cananzi AR, Perini F, Hasselmark L. Platelet models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia 1995; 15:265-71.
12. Grotemeyer KH. The platelet reactivity test. A useful 'byproduct' of the bloodsampling procedure? Thromb Res 1991; 63:587-93.
13. Kiesewetter H, Radke H, Schneider R, Mussler K. Das Mini- Erythrozytenaggregometer: ein neues Gerät zur schnellen Quantifizierung des Ausmasses der Erythrozytenaggregation. Biomed Tech 1992; 27:209-13.
14. Zeller JA, Lindner V, Frahm K, Baron R, Deuschl G. Platelet activation and platelet-leukocyte interaction in patients with migraine. Subtype differences and influence of triptans. Cephalalgia 2005; 25:536-41.
15. De Keyser J, Vauquelin G, de Backer JP, de Vos H, Wilzak N. What intracranial tissues in humans contain sumatriptan-sensitive serotonin 5-HT1-type receptors? Neurosci Lett 1993; 164:63-6.
16. Peroutka SJ. Molecular biology of serotonin (5-HT) receptors. Synapse 1994; 18:241-60.
17. Silberstein WD. The pharmacology of ergotamine and dihydroergotamine. Headache 1997; 37 (Suppl. 1):S15-S25.
18. Sanderson HM, Heptinstall S, Vickers J, Losche W. Studies in the effects of agonists and antagonists on platelet shape and platelet aggregation in whole blood. Blood Coagul Fibrinolysis 1996; 7:245-8.
19. Qi R, Ozaki Y, Satoh K, Kurota K, Asazuma N, Yatomi Y, Kume S. Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin. Thromb Res 1996; 81:43-54.
20. Chant C, Fagan SC, Aurora SK, Gidal BE, Joseph R. Effects of aspirin on platelet aggregation in smokers and non-smokers. Ann Pharmacother 1997; 31:290-3.
21. Samra SK, Harrison RL, Bee DE, Valero V. A study of aspirin induced changes in bleeding time, platelet aggregation, and Sonoclot coagulation analysis in humans. Ann Clin Lab Sci 1991; 21:315-27.
22. Seymour RA, Williams FM, Oxley A, Ward A, Fearns M, Brighan K et al. A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding time. Eur J Clin Pharmacol 1984; 26:567-71.
23. El Bouhmadi A, Laffargue F, Raspal N, Brun JF. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. Clin Hemorheol Microcirc 2000; 22:99-106.